Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-15

Clinical Trial Update: Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma [Phase 1]

View source ↗

Summary

Phase 1 clinical efficacy study results for the salmeterol xinafoate/fluticasone propionate inhaler in asthma have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salmeterol xinafoate / fluticasone propionate (Salmeterol xinafoate / fluticasone propionate)

Snippet

Sponsor: Oriel Therapeutics | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2017-06-15